Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$1.3 million.

  • Metagenomi's Other Working Capital Changes fell 4887.89% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 89426.99%. This contributed to the annual value of -$3.4 million for FY2024, which is 18405.83% down from last year.
  • Latest data reveals that Metagenomi reported Other Working Capital Changes of -$1.3 million as of Q3 2025, which was down 4887.89% from -$581000.0 recorded in Q2 2025.
  • Metagenomi's Other Working Capital Changes' 5-year high stood at $3.1 million during Q3 2023, with a 5-year trough of -$2.2 million in Q1 2025.
  • Over the past 3 years, Metagenomi's median Other Working Capital Changes value was -$581000.0 (recorded in 2025), while the average stood at -$318272.7.
  • Examining YoY changes over the last 5 years, Metagenomi's Other Working Capital Changes showed a top increase of 30085.65% in 2024 and a maximum decrease of 78560.0% in 2024.
  • Quarter analysis of 3 years shows Metagenomi's Other Working Capital Changes stood at $1.6 million in 2023, then tumbled by 175.78% to -$1.2 million in 2024, then decreased by 7.7% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, -$581000.0 for Q2 2025, and -$2.2 million during Q1 2025.